GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » GE HealthCare Technologies Inc (MEX:GEHC) » Definitions » Revenue

GE HealthCare Technologies (MEX:GEHC) Revenue : MXN372,509 Mil (TTM As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is GE HealthCare Technologies Revenue?

GE HealthCare Technologies's revenue for the three months ended in Dec. 2024 was MXN110,931 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2024 was MXN372,509 Mil. GE HealthCare Technologies's Revenue per Share for the three months ended in Dec. 2024 was MXN241.68. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was MXN811.57.

Warning Sign:

GE HealthCare Technologies Inc revenue growth has slowed down over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of GE HealthCare Technologies was 0.40% per year. During the past 3 years, the average Revenue per Share Growth Rate was 3.50% per year. During the past 5 years, the average Revenue per Share Growth Rate was 3.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 6 years, GE HealthCare Technologies's highest 3-Year average Revenue per Share Growth Rate was 4.20% per year. The lowest was 3.40% per year. And the median was 3.50% per year.


GE HealthCare Technologies Revenue Historical Data

The historical data trend for GE HealthCare Technologies's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GE HealthCare Technologies Revenue Chart

GE HealthCare Technologies Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Revenue
Get a 7-Day Free Trial 341,426.29 360,738.69 357,576.14 331,880.50 410,273.33

GE HealthCare Technologies Quarterly Data
Dec19 Dec20 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 88,367.94 77,172.59 88,650.98 95,753.93 110,931.47

Competitive Comparison of GE HealthCare Technologies's Revenue

For the Health Information Services subindustry, GE HealthCare Technologies's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GE HealthCare Technologies's Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, GE HealthCare Technologies's Revenue distribution charts can be found below:

* The bar in red indicates where GE HealthCare Technologies's Revenue falls into.


;
;

GE HealthCare Technologies Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN372,509 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GE HealthCare Technologies  (MEX:GEHC) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


GE HealthCare Technologies Revenue Related Terms

Thank you for viewing the detailed overview of GE HealthCare Technologies's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


GE HealthCare Technologies Business Description

Traded in Other Exchanges
Address
500 West Monroe Street, Chicago, IL, USA, 60661
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).